News

on
Cure Sickle Cell.
|
Research Feature
When the NHLBI announced the launch of the Cure Sickle Cell Initiative on September 13, many in the sickle cell disease community responded with enthusiasm. Patients, family members, and advocates took to social media and other channels to say they are ready to do their part, starting with spreading the news about the initiative to their neighbors,...
Text logo of Cure Sickle Cell
|
News Release
The National Institutes of Health (NIH) today announced the launch of a new initiative to help speed the development of cures for sickle cell disease, a group of inherited blood disorders affecting at least 100,000 people in the United States and 20 million worldwide. The Cure Sickle Cell Initiative will take advantage of the latest genetic discove...
African american patient in pain with female nurse
Pain is one of the unfortunate hallmarks of sickle cell disease, often growing in intensity as patients age. It is a leading cause of emergency room visits and hospitalizations among people with the disease, and the frequency of those pain-related hospital admissions is a strong predictor of premature death. Researchers have tried for years to find...
Nkechinyem (Nke) Nwabuzor
|
Research Feature
They ranged in age from 15 to 61—four African American women, all with stories to tell about their struggles with sickle cell disease, all with stories about a common experience that helped them through those struggles: participating in clinical trials. It mattered, said the women, all of whom had joined trials funded by the National Institutes of...
Microscopic view of sickle, and normal blood cells.
|
Research Feature
The notion of altering a person’s genes to cure disease used to be the stuff of science fiction. But gene editing experiments aimed at the genetic disorder that causes sickle cell disease are now making their way from the laboratory to clinical trials. And researchers supported by the National Heart, Lung, and Blood Institute (NHLBI) are hoping tho...
Dr. Wally Smith  a professor of sickle cell disease at Virginia Commonwealth University in Richmond
|
Research Feature
As the country struggles with the devastating opioid crisis, researchers say it could have dire consequences for one population with few pain-relieving alternatives: people living with sickle cell disease. The increasingly tight restrictions on opioid access, they say, is stirring fears that patients will face greater scrutiny than they already do...